Literature DB >> 28253202

Evaluation of the shielding in a treatment room with an electronic brachytherapy unit.

Blanca Ibanez-Rosello1, Juan Antonio Bautista-Ballesteros, Cristian Candela-Juan, Juan Ignacio Villaescusa, Facundo Ballester, Javier Vijande, Jose Perez-Calatayud.   

Abstract

Esteya® (Elekta Brachytherapy, Veenendaal, The Netherlands) is an electronic brachytherapy (eBT) system based on a 69.5 kVp x-ray source and a set of collimators of 1 to 3 cm in diameter, used for treating non-melanoma skin cancer lesions. This study aims to estimate room shielding requirements for this unit. The non-primary (scattered and leakage) ambient dose equivalent rates were measured with a Berthold LB-133 monitor (Berthold Technologies, Bad Wildbad, Germany). The latter ranges from 17 mSv h-1 at 0.25 m distance from the x-ray source to 0.1 mSv h-1 at 2.5 m. The necessary room shielding was then estimated following US and some European guidelines. The room shielding for all barriers considered was below 2 mmPb. The dose to a companion who, exceptionally, would stay with the patient during all treatment was estimated to be below 1 mSv if a leaded apron is used. In conclusion, Esteya shielding requirements are minimal.

Entities:  

Mesh:

Year:  2017        PMID: 28253202     DOI: 10.1088/1361-6498/aa56cf

Source DB:  PubMed          Journal:  J Radiol Prot        ISSN: 0952-4746            Impact factor:   1.394


  2 in total

1.  Recommendations of the Spanish brachytherapy group (GEB) of Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM) for high-dose rate (HDR) non melanoma skin cancer brachytherapy.

Authors:  S Rodríguez; M Arenas; C Gutierrez; J Richart; J Perez-Calatayud; F Celada; M Santos; A Rovirosa
Journal:  Clin Transl Oncol       Date:  2017-08-14       Impact factor: 3.405

2.  Two years results of electronic brachytherapy for basal cell carcinoma.

Authors:  Rosa Ballester-Sánchez; Olga Pons-Llanas; Cristian Candela-Juan; Blanca de Unamuno-Bustos; Francisco Javier Celada-Alvarez; Alejandro Tormo-Mico; Jose Perez-Calatayud; Rafael Botella-Estrada
Journal:  J Contemp Brachytherapy       Date:  2017-06-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.